60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
60 Degrees Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -774.9%. For fiscal 2025 it was -771.6%, against -1599.0% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -771.6% | +827.4 |
| FY2024 | Dec 31, 2024 | -1599.0% | +433.8 |
| FY2023 | Dec 31, 2023 | -2032.8% | −1248.6 |
| FY2022 | Dec 31, 2022 | -784.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1092.4% | +499.1 |
| Q1 FY2026 | Mar 31, 2026 | -1292.5% | −124.1 |
| Q4 FY2025 | Dec 31, 2025 | -632.0% | +222.7 |
| Q3 FY2025 | Sep 30, 2025 | -531.4% | +1034.6 |
| Q2 FY2025 | Jun 30, 2025 | -1591.5% | +1760.3 |
| Q1 FY2025 | Mar 31, 2025 | -1168.4% | +102.0 |
| Q4 FY2024 | Dec 31, 2024 | -854.7% | +652.4 |
| Q3 FY2024 | Sep 30, 2024 | -1566.0% | +1406.9 |
| Q2 FY2024 | Jun 30, 2024 | -3351.8% | −2028.1 |
| Q1 FY2024 | Mar 31, 2024 | -1270.4% | +4265.8 |
| Q4 FY2023 | Dec 31, 2023 | -1507.1% | −1379.2 |
| Q3 FY2023 | Sep 30, 2023 | -2972.9% | −1452.2 |
| Q2 FY2023 | Jun 30, 2023 | -1323.7% | – |
| Q1 FY2023 | Mar 31, 2023 | -5536.1% | – |
| Q3 FY2022 | Sep 30, 2022 | -127.9% | – |
| Q2 FY2022 | Jun 30, 2022 | -1520.6% | – |